title: Optimisation and quality control of cell processing for autologous stem cell transplantation.
abstract: Clinical practice and the technology of cell processing for autologous stem cell transplantation has continued to evolve over the last two decades and merits review of current quality control expectations. The external regulatory era has improved quality and safety standards but there is still variable practice, with specific risks illuminated by a number of clinical incidents. Viable CD34+cell assays may fail to indicate significant losses in progenitor function during storage, particularly after cryopreservation, and there is a need to develop an alternative, real time functional assay to replace colony assays. The ultimate guide to potency and successful cell processing for haematopoietic progenitor cell products is prompt and reproducible engraftment and close monitoring is essential for safety and quality control.
authors.affiliation: University College London Hospitals, London, UK.|University College London, London, UK.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Watts
authors.affiliation: University College London Hospitals, London, UK.|University College London, London, UK.
authors.forename: David C
authors.initials: DC
authors.lastname: Linch
mesh_terms: D015925:Cryopreservation / Q000592:standards; D006085:Graft Survival; D018380:Hematopoietic Stem Cell Transplantation / Q000592:standards*; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D011786:Quality Control; D014182:Transplantation, Autologous
keywords: cryopreservation; engraftment kinetics; potency; quality control; viability